C-Path’s Transplant Therapeutics Consortium Receives Acceptance of Letter of Intent for iBox Scoring System (Composite Biomarker Panel) as a Reasonably Likely Surrogate Endpoint

Posted on Wed/17/JuneWed/17/June by Roxan Olivas

Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplant recipients.

TUCSON, Ariz., June 17, 2020 — Critical Path Institute (C-Path) announced today that its Transplant Therapeutics Consortium (TTC) has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the decision to accept the Composite Biomarker Panel (iBox Scoring System) into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).Continue reading→

All of Us Research Program launches COVID-19 research initiatives

Posted on Tue/16/JuneTue/16/June by AZBio

Banner Health and University of Arizona support national data collection effort to shed light on pandemic’s spread and impact

Continue reading→

COVID-19 Update #5 shared by an Arizona Emergency Physician and Legislator

Posted on Mon/15/JuneThu/18/June by AZBio

Amish Shah, MD is an emergency physician at Dignity Health and a member of the Arizona House of Representative elected by the people of LD24 – Central Phoenix and South Scottsdale. On Sunday, June 14, 2020, Dr. Shah shared the message below via Facebook. With his permission, we are sharing it with you.

Continue reading→

New Report Examines Bioscience Industry’s Economic Impact in Arizona & Role in Global Pandemic

Posted on Sun/14/JuneSun/14/June by AZBio

Chandler, Arizona – The Biotechnology Innovation Organization (BIO) released new data on the bioscience industry in the United States. The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, analyzes the bioscience industry’s economic footprint across the nation and in Arizona, the significant role of small- and mid-sized companies, and the industry’s response to the COVID-19 pandemic.Continue reading→

ICYMI – Great BIO Digital Sessions Available Online

Posted on Fri/12/JuneMon/15/June by AZBio

Select Sessions From BIO Digital Week Now Available!Continue reading→

Pediatric experts warn against delaying well-child visits

Posted on Tue/9/JuneTue/9/June by AZBio

CDC reports drop in recommended child vaccinationsContinue reading→

Humabiologics Inc. Reaches $1M Seed Round Funding Milestone

Posted on Fri/5/JuneFri/5/June by AZBio

PHOENIX, Ariz.– Humabiologics Inc., a regenerative medicine company founded by scientists and tissue industry experts, announced today it has successfully raised $1 million in seed funding.Continue reading→

RCT Acquires Translational Drug Development, LLC

Posted on Fri/5/JuneFri/18/December by AZBio

Tucson, Ariz. & Scottsdale, Ariz. / June 4, 2020
Research Corporation Technologies, Inc. (RCT) announced today that it has acquired and invested growth capital into Translational Drug Development (TD2), the leading fully integrated precision oncology medicine development organization.
TD2 provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovative oncology-focused companies.Continue reading→

IMNA Announces New Appointment to Its Board Of Directors

Posted on Tue/2/JuneTue/2/June by AZBio

IMNA Solutions announced today that it has appointed Russ Yelton, President/CEO of Yelton and Associates and Chairman of The Board of Trustees of AZAdvances to its board of directorsContinue reading→

ASU develops state’s first saliva-based COVID-19 test

Posted on Mon/1/JuneThu/18/June by AZBio

In an effort to make COVID-19 diagnostic testing easier and more readily available to Arizonans, researchers at Arizona State University have developed the state’s first saliva-based test.Continue reading→